跳至主要内容
临床试验/JPRN-UMIN000038413
JPRN-UMIN000038413招募中未知

Prospective multicenter observation study of anti-PD-1/PD-L1 antibody re-treatment who previously treated with anti-PD-1/PD-L1 antibody plus chemotherapy - NJLCG1901 Prospective multicenter observation study of anti-PD-1/PD-L1 antibody re-treatment who previously treated with anti-PD-1/PD-L1 antibody plus chemotherapy

orth Japan Lung Cancer Study Group0 个研究点目标入组 70 人开始时间: 2019年11月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Active double cancer 2) Patients with a history of severe immune-related adverse events associated with anti-PD-1/PD-L1 antibody 3) Patients with active autoimmune disease 4) Patients with infectious disease requiring systemic treatment 5) Radiographically confirmed interstitial pneumonitis or pulmonary fibrosis 6) Patients with significant complications 7) Patiens who are undergoing systemic administration of steroid greater than 10mg daily of prednisone 8) History or severe drug allergies 9) Pregnant females, possibly pregnant females, females wishing to become pregnant, females of breastfeeding and males wishing to their partner's pregnant 10) Physician concludes that the patient's participation is inappropriate

研究者

发起方
orth Japan Lung Cancer Study Group

相似试验